... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Dyslipidemia Fibroblast growth factor 23 Hypertension Nephrotic syndrome Pediatric hypertension NIH The primary...

... outcomes. Therapeutic strategies in this patient population aim at controlling modifiable cardiovascular risk factors, including dyslipidemia. Summary: In this review article, we first provide the latest pathophysiologic evidence regarding the altered dyslipidemia pattern in CKD, followed by its...

.... The association of FGF23 with death was attenuated after adjustment for HDL-C (HR of highest quartile 1.53, 95% CI 1.06-2.20 compared to lowest quartile). Conclusion: These results indicate that higher plasma FGF23 levels are associated with lower BMI and dyslipidemia in dialysis patients. The association between...

...Nosratola D. Vaziri; Yongli Bai; Jun Yuan; Hannah L. Said; Whitney Sigala; Zhemin Ni Background: Chronic kidney disease (CKD) results in accelerated atherosclerosis and cardiovascular disease. This is primarily mediated by oxidative stress, inflammation and dyslipidemia. By mediating reverse...

...-angiotensin system seems to have a beneficial effect on uremic dyslipidemia [ 82 ]. Losartan reduces oxidative stress, renal fibrosis and TGF-β expression in rats with NO deficiency, subtotal nephrectomy, or unilateral ureteral obstruction [ 83,84,85 ]. Olmesartan also prevents renal damage in Imai rats...

... artery continues to dilate 2 years after access creation, with a simultaneous decrease in WSR. This process is dampened in patients with diabetes mellitus and dyslipidemia. 7 02 2008 9 03 2008 6 6 2008 Table 2 Hemodynamic variables at baseline, and years 1 and 2 acces creation...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Dyslipidemia Insulin resistance Obesity Chronic kidney disease We [ 1, 2 ] have...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Arterial stiffness Chronic kidney disease Hypertension Dyslipidemia Cardiovascular disease Cardiovascular...

...Christine K. Abrass Dyslipidemia contributes to the rate of progression of atherosclerosis and chronic kidney disease. Also, chronic kidney disease leads to the development of secondary abnormalities in lipid metabolism that contribute to increased cardiovascular morbidity and mortality...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Hemodialysis Dyslipidemia L -Carnitine Hypertriglyceridemia Clinical Study Am J Nephrol 1998;18:416 421 Received...